Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
NCT00196768Phase 4Unknown
- Sponsor
- German AML Cooperative Group
- Start
- Jan 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by German AML Cooperative Group. Status: unknown.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00196768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196768.